Andrés Gaviria-Mendoza

Dr. Andrés Gaviria-Mendoza

Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 November 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Jorge Enrique Machado-AlbaJorge Enrique Machado-Alba
Jorge Enrique Machado-Alba
LVLuis Fernando Valladales-Restrepo
Luis Fernando Valladales-Restrepo
MMManuel Enrique Machado-Duque
Manuel Enrique Machado-Duque
AGAndrés Gaviria-Mendoza
Andrés Gaviria-Mendoza
NSNicolás Sánchez-Ramírez
Nicolás Sánchez-Ramírez
ASAlejandra Sabogal-Ortiz
Alejandra Sabogal-Ortiz
Introduction: Coronavirus disease 2019 (COVID-19) has affected millions of people worldwide, and several sociodemographic variables, comorbidities and care variables have been associated with complications and mortality. Objective: To identify the factors associated with admission to intensive care units (ICUs) and mortality in patients with COVID-19 from 4 clinics in Colombia. Methods: This was a follow-up study of a cohort of patients diagnosed with COVID-19 between March and August 2020. Sociodemographic, clinical (Charlson comorbidity index and NEWS 2 score) and pharmacological variables were identified. Multivariate analyses were performed to identify variables associated with the risk of admission to the ICU and death (p<0.05). Results: A total of 780 patients were analyzed, with a median age of 57.0 years; 61.2% were male. On admission, 54.9% were classified as severely ill, 65.3% were diagnosed with acute respiratory distress syndrome, 32.4% were admitted to the ICU, and 26.0% died. The factors associated with a greater likelihood of ICU admission were severe pneumonia (OR: 9.86; 95%CI:5.99–16.23), each 1-point increase in the NEWS 2 score (OR:1.09; 95%CI:1.002–1.19), history of ischemic heart disease (OR:3.24; 95%CI:1.16–9.00), and chronic obstructive pulmonary disease (OR:2.07; 95%CI:1.09–3.90). The risk of dying increased in those older than 65 years (OR:3.08; 95%CI:1.66–5.71), in patients with acute renal failure (OR:6.96; 95%CI:4.41–11.78), admitted to the ICU (OR:6.31; 95%CI:3.63–10.95), and for each 1-point increase in the Charlson comorbidity index (OR:1.16; 95%CI:1.002–1.35). Conclusions: Factors related to increasing the probability of requiring ICU care or dying in patients with COVID-19 were identified, facilitating the development of anticipatory intervention measures that favor comprehensive care and improve patient prognosis.

1 January 2022 in Therapeutic Advances in Drug Safety
Verified
Journal Article
Open access
AGAndrés Gaviria-Mendoza
Andrés Gaviria-Mendoza
DMDanny Alberto Mejía-Mazo
Danny Alberto Mejía-Mazo
CDCarolina Duarte-Blandón
Carolina Duarte-Blandón
JCJuan Daniel Castrillón-Spitia
Juan Daniel Castrillón-Spitia
MMManuel Enrique Machado-Duque
Manuel Enrique Machado-Duque
Jorge Enrique Machado-AlbaJorge Enrique Machado-Alba
Jorge Enrique Machado-Alba
Aim: Quarantine due to the COVID-19 pandemic altered the supply and demand of health services. This, together with the ‘infodemic’ and generalized panic, could alter the patterns of self-medication in the population. The objective was to characterize the patterns of self-medication in four cities of Colombia during mandatory preventive isolation in 2020. Methods: This was a cross-sectional study done in four Colombian cities during mandatory national preventive isolation between June and September 2020. A sample of 397 adults who responded to an online survey, based on the Instrument for Systematic Data Collection for Self-medication ( Instrumento de Recolección Sistemática de Datos para la Automedicación–IRIS-AM), was obtained. The use of social networks (including WhatsApp) as the source of information about medications was explored. Results: The 397 people surveyed had a median age of 31.0 years, and 58.2% were women. The prevalence of self-medication during lockdown was 34.3% ( n = 136). Medications targeting the nervous system ( n = 117; 86.0% of those participants with self-medication) and the musculoskeletal system ( n = 68; 50.0%) were the most commonly used. Ten (7.4%) of the self-medicated patients reported doing so to prevent COVID-19, and 15 (11.0%) named social networks as the source of information. Conclusion: More than one-third of the participants reported self-medication during COVID-19 lockdown, mainly with analgesic-type nervous system medications. People who reported self-medication to prevent COVID-19 often got their information from social networks, the Internet, and WhatsApp. Plain Language Summary: Self-medication during mandatory COVID-19 isolation Introduction: Self-medication refers to the use of medications to treat self-diagnosed disorders or symptoms, and it can lead to health problems. This habit is widely practiced by the people, especially in low- and middle-income countries. The objective was to characterize the patterns of self-medication in four cities of Colombia during mandatory preventive isolation in 2020 due the quarantine by COVID-19 explored pandemic. Methods: We made a cross-sectional study between June and September 2020, and a sample of 397 adults who responded to an online survey. The use of social networks (including WhatsApp) as the source of information about medications was explored. Results: The prevalence of self-medication during lockdown was 34.3% ( n = 136). Medications targeting the nervous system ( n = 117; 86.0% of those participants with self-medication) and the musculoskeletal system (strategies n = 68; 50.0%) were the most commonly used. Conclusion: People who reported self-medication to prevent COVID-19 often got their information from social networks, the Internet, and WhatsApp. These findings raise the possibility of designing pedagogical strategies on this topic.

8 July 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
Jorge Enrique Machado-AlbaJorge Enrique Machado-Alba
Jorge Enrique Machado-Alba
LRLuis Fernando Valladales Restrepo
Luis Fernando Valladales Restrepo
AGAndrés Gaviria-Mendoza
Andrés Gaviria-Mendoza
Jorge Enrique Machado-AlbaJorge Enrique Machado-Alba
Jorge Enrique Machado-Alba
Albert FiguerasAlbert Figueras
Albert Figueras
The use of antibiotics is the most important modifiable risk factor for the development of microorganism resistance. A cross-sectional study of outpatients receiving antibiotic prescriptions registered in a population database in Colombia was conducted. The characteristics of the consumption in capital cities and small municipalities was studied and the AWaRe classification was used. AWaRe classifies antibiotics into three stewardship groups: Access, Watch and Reserve, to emphasize the importance of their optimal use and potential harms of antimicrobial resistance. A total of 182,397 patients were prescribed an antibiotic; the most common were penicillins (38.6%), cephalosporins (30.2%) and fluoroquinolones (10.9%). ‘Access’ antibiotics (86.4%) were the most frequently prescribed, followed by ‘Watch’ antibiotics (17.0%). Being 18 or older, being male, living in a municipality, having one or more comorbidities and urinary, respiratory or gastrointestinal disorders increased the probability of receiving ‘Watch’ or ‘Reserve’ antibiotics. Penicillin and urinary antiseptic prescriptions predominated in cities, while cephalosporin and fluoroquinolone prescriptions predominated in municipalities. This analysis showed that the goal set by the WHO Access of mainly using Access antibiotics is being met, although the high use of Watch antibiotics in municipalities should be carefully studied to determine if it is necessary to design specific campaigns to improve antibiotics use.

21 May 2016 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
PMPaula Andrea Moreno‐Gutiérrez
Paula Andrea Moreno‐Gutiérrez
AGAndrés Gaviria-Mendoza
Andrés Gaviria-Mendoza
MCMauricio Montoya Cañón
Mauricio Montoya Cañón
Jorge Enrique Machado-AlbaJorge Enrique Machado-Alba
Jorge Enrique Machado-Alba

18 February 2017 in Muscle & Nerve
Verified
Journal Article
Closed access
PDF file
Jorge Enrique Machado-AlbaJorge Enrique Machado-Alba
Jorge Enrique Machado-Alba
LCLuis Felipe Calvo‐Torres
Luis Felipe Calvo‐Torres
AGAndrés Gaviria-Mendoza
Andrés Gaviria-Mendoza
CMCésar Augusto Mejía‐Vélez
César Augusto Mejía‐Vélez

15 February 2023 in Expert Opinion on Pharmacotherapy
Verified
Journal Article
Closed access
LRLuis Fernando Valladales Restrepo
Luis Fernando Valladales Restrepo
NSNicolás Sánchez-Ramírez
Nicolás Sánchez-Ramírez
AUAndrés Felipe Usma-Valencia
Andrés Felipe Usma-Valencia
AGAndrés Gaviria-Mendoza
Andrés Gaviria-Mendoza
Jorge Enrique Machado-AlbaJorge Enrique Machado-Alba
Jorge Enrique Machado-Alba
Jorge Enrique Machado-AlbaJorge Enrique Machado-Alba
Jorge Enrique Machado-Alba
To determine the effectiveness, persistence of use, adverse reactions, interactions of orlistat and liraglutide taken for weight loss by a group of obese patients in Colombia.A retrospective follow...